FTC Rips Gilead's 'Erroneous' Argument In HIV Drug Rumble
By Adam Lidgett · October 28, 2019, 6:45 PM EDT
The Federal Trade Commission has waded into a lawsuit accusing Gilead Sciences Inc. of creating an HIV drug empire by using shadowy deals to block generic competition, assailing the company's argument...
To view the full article, register now.